| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 20.19B | 20.00B | 19.42B | 17.47B | 14.44B | 13.63B |
| Gross Profit | 6.49B | 6.09B | 5.61B | 4.99B | 3.28B | 2.53B |
| EBITDA | 3.37B | 3.35B | 3.07B | 2.89B | 1.58B | 735.45M |
| Net Income | 1.12B | 1.09B | 1.06B | 897.87M | -434.38M | -972.79M |
Balance Sheet | ||||||
| Total Assets | 55.87B | 56.45B | 56.72B | 56.79B | 56.77B | 57.50B |
| Cash, Cash Equivalents and Short-Term Investments | 2.55B | 2.66B | 2.71B | 2.49B | 2.52B | 2.44B |
| Total Debt | 25.65B | 26.68B | 27.76B | 29.48B | 30.66B | 31.53B |
| Total Liabilities | 36.65B | 37.42B | 38.63B | 39.81B | 40.50B | 40.86B |
| Stockholders Equity | 19.22B | 19.03B | 18.09B | 16.99B | 16.27B | 16.63B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.56B | 2.06B | 1.32B | 1.00B | -2.46B |
| Operating Cash Flow | 0.00 | 2.57B | 2.88B | 2.68B | 2.14B | 509.02M |
| Investing Cash Flow | 0.00 | -1.19B | -849.79M | -1.45B | -1.21B | -3.12B |
| Financing Cash Flow | 0.00 | -1.43B | -1.82B | -1.25B | -855.22M | 3.29B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥237.92B | 4.69 | 12.70% | 1.68% | 8.29% | 24.94% | |
72 Outperform | ¥7.93B | 7.03 | ― | 0.47% | 3.15% | 4.75% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥19.62B | -109.80 | ― | 1.33% | 1.70% | 1841.47% | |
62 Neutral | ¥45.41B | 9.60 | ― | 2.58% | 2.36% | -40.95% | |
59 Neutral | ¥20.24B | 9.88 | ― | 0.81% | 1.24% | 19.78% | |
54 Neutral | ¥3.16B | 14.00 | ― | ― | 9.04% | ― |